Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment 1.88
James Lomas, Jessica Ochalek, Rita Faria
Applied Health Economics and Health Policy, vol. 20, 2022, p. 13-18.

A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. 4.68
Rita Faria, Manuel Gomes, David Epstein, Ian White
Pharmacoeconomics, vol. 32, 2014, p. 1157-1170.